TCM Biotech International Corp. (TPEX:4169)
Taiwan
· Delayed Price · Currency is TWD 51.30
+0.40 (0.79%)
May 13, 2025, 1:22 PM CST
TCM Biotech International Revenue
In the year 2024, TCM Biotech International had annual revenue of 666.53M TWD, down -31.26%. TCM Biotech International had revenue of 336.59M in the half year ending December 31, 2024, a decrease of -21.63%.
Revenue
666.53M
Revenue Growth
-31.26%
P/S Ratio
4.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 666.53M | -303.09M | -31.26% |
| Dec 31, 2023 | 969.62M | 167.20M | 20.84% |
| Dec 31, 2022 | 802.42M | 100.38M | 14.30% |
| Dec 31, 2021 | 702.05M | -35.03M | -4.75% |
| Dec 31, 2020 | 737.08M | 168.45M | 29.62% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 43.59M |
| Pegavision | 6.69B |